Cargando…
Posterior Reversible Encephalopathy Syndrome Associated with Oxaliplatin Use for Pancreatic Adenocarcinoma
The posterior reversible encephalopathy syndrome (PRES) was first described by Hinchey's group in 1996 as a reversible vasogenic brain edema on magnetic resonance imaging (MRI). Hypertension represents the most frequent manifestation associated with PRES. In the present report, we present a pat...
Autores principales: | Symeonidis, David G., Liatsos, Alexandros D., Mazlimoglou, Evridiki K., Geraki, Eleni C., Kosmas, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255710/ https://www.ncbi.nlm.nih.gov/pubmed/34248548 http://dx.doi.org/10.1159/000515076 |
Ejemplares similares
-
Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? The MeTHOS cohort study
por: Xynogalos, Spyridon, et al.
Publicado: (2022) -
Posterior reversible encephalopathy syndrome postpartum
por: Nielsen, Lise Hald, et al.
Publicado: (2015) -
Posterior reversible encephalopathy syndrome(PRES)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2017) -
Posterior reversible encephalopathy syndrome in a woman with pancreatitis
por: Luo, Jie, et al.
Publicado: (2019) -
Posterior reversible encephalopathy syndrome at term pregnancy
por: Achar, Shreepathi Krishna, et al.
Publicado: (2011)